This isn’t Black Bird Biotech, Inc.’s most recent raise. Private · Debt · Jan 2023 (Closed) is more current.View latest round

Reg A+ · Equity · Aug 2021

ClosedReg A+Equity

via the platform · last checked Sep 29, 2026

Raised

$245K / $2.5M max

10% of ceiling

Investors

—

Estimated pre-money

$9.6M

—

Financials disclosed in this offering

FY2020 · hover for source

$58K

−$690K

FY2020

RevenueNet income

Metric

FY2020 audited

Income statement

Revenue

$57,604

Cost of goods sold

$28,245

Gross margin

51%

Net income

-$690,158

Taxes paid

Balance sheet

Cash

$52,974

Accounts receivable

Total assets

$126,150

Short-term debt

$45,617

Long-term debt

Total liabilities

$98,541

Other

Headcount

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment

Sep 16, 2021
Terms not yet extracted from this filing
Form 1-A POS on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$9.6M

Price / share$0.05

Shares offered50,000,000

Estimated, not stated: $0.05 × 191,675,352 securities outstanding.

Offering details

Target—

Max$2,500,000

Min investment—

OpenedAug 31, 2021

Deadline—

Days active1,866

Links & provenance

SEC filing

Source: SEC EDGAR
0001477932-21-006050
Last synced Sep 29, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.